Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study

Area of Science:

• Oncology
• Genetics
• Medical Imaging

Background:

• High-risk breast cancer screening for BRCA1/2 mutation carriers utilizes clinical breast exams, mammography, and MRI.
• Despite high sensitivity, interval cancers still occur in BRCA1/2 mutation carriers.
• Understanding screening patterns in this cohort is crucial for improving outcomes.

Purpose of the Study:

• To investigate the presentation and screening patterns of breast cancer in an Irish cohort of BRCA1/2 mutation carriers.
• To analyze the effectiveness of current screening modalities in detecting breast cancer within this high-risk population.

Main Methods:

• Retrospective cohort study of BRCA1/2 mutation carriers diagnosed with breast cancer.
• Review of medical records for mutation status, demographics, screening regimen, and diagnostic modality.
• Analysis of cancer detection methods and occurrence of second primary breast cancers.

Main Results:

• Fifty-three breast cancers were diagnosed in 60 Irish hereditary breast ovarian cancer families; most preceded mutation identification.
• Clinical breast exam detected 80% of cancers identified by screening, followed by mammography (12%) and MRI (8%).
• 26% of women developed a second breast cancer, with 71% in regular screening; 30% were detected by clinical breast exam alone.

Conclusions:

• Inconsistent compliance with screening protocols was observed in this Irish cohort of BRCA1/2 mutation carriers.
• A significant 30% incidence of interval cancers highlights limitations in current high-risk screening strategies.
• Preventive surgery may be a more effective risk reduction approach for select high-risk women.